93 7226 93 7226 (Selfemra 20 mg)
Generic Name: fluoxetine
Pill imprint 93 7226 93 7226 has been identified as Selfemra 20 mg.
Selfemra is used in the treatment of premenstrual dysphoric disorder and belongs to the drug class selective serotonin reuptake inhibitors. Risk cannot be ruled out during pregnancy. Selfemra 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- fluoxetine
- Imprint:
- 93 7226 93 7226
- Strength:
- 20 mg
- Color:
- Blue & Pink
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Selective serotonin reuptake inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7226
More about Selfemra (fluoxetine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: selective serotonin reuptake inhibitors
Consumer resources
Other brands: Prozac, Sarafem, Prozac Weekly, Rapiflux
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
